Sinclair’s Life Biosciences Secures $80M to Pioneer Gene Therapy Trials
Sinclair’s Life Biosciences secures $80M, highlighting a significant shift in innovative longevity therapies and gene therapy.
Sinclair’s Life Biosciences secures $80M, highlighting a significant shift in innovative longevity therapies and gene therapy.
Discover why lifestyle choices, not tech, drive longevity. Learn how community and habits can outlast Silicon Valley’s promises.
Discover how proline is proving essential in restoring mitochondrial function and combating aging.
Discover the implications of anti-aging breakthroughs on population growth and resource management by 2050.